|
|
||||||||
1 Department of Pediatrics and
2 Department of Medicine,
In vitro studies have suggested that
dopamine D1- and
D2-like receptors interact to
inhibit renal sodium transport. We used Z-1046, a dopamine receptor
agonist with the rank-order potency D3
D4 > D2 > D5 > D1, to test the hypothesis that
D1- and
D2-like receptors interact to
inhibit renal sodium transport in vivo in anesthetized rats. Increasing
doses of Z-1046, administered via the right renal artery, increased
renal blood flow (RBF), urine flow, and absolute and fractional sodium
excretion without affecting glomerular filtration rate. For
determination of the dopamine receptor involved in the renal
functional effects of Z-1046, another group of rats received
Z-1046 at 2 µg · kg
1 · min
1
(n = 10) in the presence or absence of
the D2-like receptor antagonist domperidone and/or the
D1-like antagonist SCH-23390.
Domperidone alone had no effect but blocked the Z-1046-mediated
increase in urine flow and sodium excretion; it enhanced the increase
in RBF after Z-1046. SCH-23390 by itself decreased urine flow and
sodium excretion without affecting RBF and blocked the diuretic,
natriuretic, and renal vasodilatory effect of Z-1046. We conclude that
the renal vasodilatory effect of Z-1046 is
D1-like receptor dependent, whereas the diuretic and natriuretic effects are both
D1- and D2-like receptor dependent.
dopamine receptors; sodium excretion; renal hemodynamics
This article has been cited by other articles:
![]() |
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. LUIPPOLD, C. ZIMMERMANN, M. MAI, D. KLOOR, D. STARCK, G. GROSS, and B. MUHLBAUER Dopamine D3 Receptors and Salt-Dependent Hypertension J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2272 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ladines, C. Zeng, L. D. Asico, X. Sun, F. Pocchiari, C. Semeraro, J. Pisegna, S. Wank, I. Yamaguchi, G. M. Eisner, et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1071 - R1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Saito, Y. Ando, E. Kusano, and Y. Asano Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD Am J Physiol Renal Physiol, July 1, 2001; 281(1): F114 - F122. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. X. Li, J. Xu, S. Zheng, F. E. Albrecht, J. E. Robillard, G. M. Eisner, and P. A. Jose D1 dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1650 - R1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Torres, A. N. Rai, and M. L. Hardiek Mercury Intoxication and Arterial Hypertension: Report of Two Patients and Review of the Literature Pediatrics, March 1, 2000; 105(3): 34e - 34. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |